Johannes Nagelschmitz
Wuppertal, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Safety and pharmacokinetics of mosliciguat, a new, inhaled soluble guanylate cyclase activator, in healthy adult subjects.
Journal: British journal of clinical pharmacology
Published: June 16, 2025
Pharmacokinetics and Lung Deposition After Administration of Inhaled Mosliciguat (BAY 1237592): Results from Randomized Phase I Studies in Healthy Men.
Journal: Clinical pharmacokinetics
Published: March 23, 2025
Results From Drug-Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3.
Journal: European journal of drug metabolism and pharmacokinetics
Published: August 07, 2022
Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC.
Journal: Respiratory research
Published: May 06, 2022
Results From Phase I Studies Investigating the Dose Linearity of Finerenone Tablets and the Influence of Food or pH-Modifying Comedications on its Pharmacokinetics in Healthy Male Volunteers.
Journal: European journal of drug metabolism and pharmacokinetics
Published: March 22, 2022
Biopharmaceutical Characteristics of Nifurtimox Tablets for Age- and Body Weight-Adjusted Dosing in Patients With Chagas Disease.
Journal: Clinical pharmacology in drug development
Published: June 25, 2020
Results from Drug-Drug Interaction Studies In Vitro and In Vivo Investigating the Effect of Finerenone on the Pharmacokinetics of Comedications.
Journal: European journal of drug metabolism and pharmacokinetics
Published: March 04, 2020
Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis.
Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: March 09, 2019
Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals with Mild or Moderate Hepatic Impairment.
Journal: European journal of drug metabolism and pharmacokinetics
Published: March 03, 2019
Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: A randomized controlled trial.
Journal: Pulmonary pharmacology & therapeutics
Published: November 28, 2018
Pharmacokinetics of the Novel, Selective, Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in Healthy Volunteers: Results from an Absolute Bioavailability Study and Drug-Drug Interaction Studies In Vitro and In Vivo.
Journal: European journal of drug metabolism and pharmacokinetics
Published: May 21, 2018
Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.
Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: July 23, 2016
Last Updated: 09/26/2026